兆科眼科-B(06622.HK) 公布，旗下全资附属子公司，兆科(广州)眼科药物有限公司，与浙江视方极医药科技有限公司，联合发布国内首款单剂量不含抑菌剂的盐酸氮(卓)斯汀滴眼液产品(顺敏)，为过敏性结膜炎患者提供更全面的治疗方案选择。
此次合作是双方在眼科药物领域发展的重要里程碑，结合兆科眼科的商业化实力及视方极的产品研发优势，双方加强互补合作，共同开辟过敏性结膜炎药物治疗新篇章。
随着两间公司在眼科药物领域的持续深耕，中国眼科治疗领域可望迎来更多的创新成果，为患者提供更安全更高效的解决方案。未来，兆科眼科与视方极将继续携手前行，共同推动眼科健康事业的发展，为更多患者带来希望与光明。(ca/da)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.